The efficacy and safety of autologous gamma/delta T cell transfer therapy after resection of intrahepatic cholangiocarcinoma or biliary tract cancer
Not Applicable
- Conditions
- Intrahepatic cholangiocarcinoma biliary tract cancer
- Registration Number
- JPRN-UMIN000001417
- Lead Sponsor
- The University of Tokyo Hospital
- Brief Summary
Presented by The 48th Annual Meeting of Japan Sopciety of Hepatology.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have: - Pulmonary fibrosis or interstitial pneumonia, or history or predisposition of them; - Active enteritis; - Active autoimmune diseases; - Active infections; - Other cancers; - Other serious complications; - Continuous systemic administration of steroids.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method